Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

NCT06883136 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Sintilimab+Cis-platinum/Carboplatin with Pemetrexed or Gemcitabine

Sponsor

Qianfoshan Hospital